Teens with heart disease try home video workouts to boost fitness

NCT ID NCT06015191

First seen May 07, 2026

Summary

This study tests whether live, group exercise sessions delivered via video chat can improve fitness in teens (ages 12-19) with certain types of congenital heart disease. 74 participants will either join the remote exercise program or receive standard exercise handouts. The main goal is to see if the remote program improves peak oxygen use during exercise (a key fitness measure) over 12 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL HEART DISEASE IN CHILDREN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Children's Mercy Kansas City

    RECRUITING

    Kansas City, Missouri, 64108, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Remote cardiac rehabilitation (live video exercise sessions)

What this could lead to

If successful, this could provide a convenient, effective way for teens with heart disease to improve their fitness and heart health from home.

What could go wrong

This is a small, early-stage trial (74 people) testing feasibility and short-term effects. The exercise program may not improve fitness more than standard advice, and long-term benefits are unknown.

Conditions

The condition(s) this trial relates to.

congenital heart disease Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.